Association of a miR-502-Binding Site Single Nucleotide Polymorphism in the 3'-Untranslated Region of SET8 and the TP53 Codon 72 Polymorphism with Cervical Cancer in the Chinese Population
This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either independently or jointly, might be associated with increased risk for cervical cancer. We genotyped SET8 and TP53 codon 72 polymorphisms of periph...
Saved in:
Published in | Asian Pacific journal of cancer prevention : APJCP Vol. 15; no. 16; pp. 6505 - 6510 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Thailand
01.01.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1513-7368 2476-762X |
DOI | 10.7314/APJCP.2014.15.16.6505 |
Cover
Abstract | This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either independently or jointly, might be associated with increased risk for cervical cancer.
We genotyped SET8 and TP53 codon 72 polymorphisms of peripheral blood DNA from 114 cervical cancer patients and 200 controls using the polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) and direct DNA sequencing.
The frequency of SET8 CC (odds ratios (OR) = 2.717, 95% CI=1.436-5.141) or TP53 GG (OR=2.168, 95% CI=1.149-4.089) genotype was associated with an increased risk of cervical cancer on comparison with the SET8 TT or TP53 CC genotypes, respectively. In additional, interaction between the SET8 and TP53 polymorphisms increased the risk of cervical cancer in a synergistic manner, with the OR being 9.913 (95% CI=2.028-48.459) for subjects carrying both SET8 CC and TP53 GG genotypes.
These data suggest that there are significant associations between the miR-502-binding site SNP in the 3'-UTR of SET8 and the TP53 codon 72 polymorphism with cervical cancer in Chinese, and there is a gene-gene interaction. |
---|---|
AbstractList | This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either independently or jointly, might be associated with increased risk for cervical cancer.
We genotyped SET8 and TP53 codon 72 polymorphisms of peripheral blood DNA from 114 cervical cancer patients and 200 controls using the polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) and direct DNA sequencing.
The frequency of SET8 CC (odds ratios (OR) = 2.717, 95% CI=1.436-5.141) or TP53 GG (OR=2.168, 95% CI=1.149-4.089) genotype was associated with an increased risk of cervical cancer on comparison with the SET8 TT or TP53 CC genotypes, respectively. In additional, interaction between the SET8 and TP53 polymorphisms increased the risk of cervical cancer in a synergistic manner, with the OR being 9.913 (95% CI=2.028-48.459) for subjects carrying both SET8 CC and TP53 GG genotypes.
These data suggest that there are significant associations between the miR-502-binding site SNP in the 3'-UTR of SET8 and the TP53 codon 72 polymorphism with cervical cancer in Chinese, and there is a gene-gene interaction. |
Author | Cai, Yan-Lin Yang, Shao-Di Li, Wen Tang, Jian-Xin Jiang, Pei |
Author_xml | – sequence: 1 givenname: Shao-Di surname: Yang fullname: Yang, Shao-Di – sequence: 2 givenname: Yan-Lin surname: Cai fullname: Cai, Yan-Lin – sequence: 3 givenname: Pei surname: Jiang fullname: Jiang, Pei – sequence: 4 givenname: Wen surname: Li fullname: Li, Wen – sequence: 5 givenname: Jian-Xin surname: Tang fullname: Tang, Jian-Xin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25169478$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUctuFDEQtFAQ2QQ-AeQbpxn8tkecllEgQRGsko3EbeTxY9doxl6NvaD8Gx_H7CZBgguX7kNXVXdXnYGTmKID4DVGtaSYvVuuPrermiDMasxrLGrBEX8GFoRJUUlBvp2ABeaYVpIKdQrOcv6OEONK8hfglHAsGibVAvxa5pxM0CWkCJOHGo7hpuKIVB9CtCFu4G0obi5xMzj4ZW8Gl0qwDq7ScD-mabcNeYQhwrJ1kL6t7mKZdMyDLs7CG7d5lL29WCuooz3C1itOYZvsPJLkb6GfoWxh66YfwegBtjoaNz2pt9sQXT5s3u2H48EvwXOvh-xePfZzcPfxYt1eVtdfP121y-vKUC5K1SArGoN7yqQnwhukRSMd10pz4ZVhijXKW-MN9bo3kpFeKUKUtLqnwtGenoM3D7q7fT862-2mMOrpvnuycQbwB4CZUs6T838gGHWHuLpjXN0hrg7zDovuENfMe_8Pz4RyfG12MQz_Yf8GcJacng |
CitedBy_id | crossref_primary_10_1016_j_mrrev_2017_06_002 crossref_primary_10_1016_j_canlet_2016_04_008 crossref_primary_10_1111_cpr_12751 crossref_primary_10_1042_BSR20160480 crossref_primary_10_4236_jbm_2020_811004 crossref_primary_10_1007_s13277_015_4467_y crossref_primary_10_7314_APJCP_2014_15_23_10387 crossref_primary_10_1042_BSR20180702 crossref_primary_10_1099_jmm_0_000563 crossref_primary_10_18632_oncotarget_9099 |
Cites_doi | 10.1128/MCB.01768-08 10.1016/j.cancergen.2012.04.010 10.1158/1541-7786.MCR-09-0117 10.1375/twin.15.1.79 10.1158/1078-0432.CCR-09-0826 10.1002/ijc.27352 10.1016/j.molcel.2007.07.012 10.7314/APJCP.2012.13.12.6423 10.1158/0008-5472.CAN-09-3541 10.7314/APJCP.2012.13.10.4909 10.1038/30400 10.1016/j.cancergencyto.2009.11.011 10.1371/journal.pone.0077024 10.1111/j.1348-0421.2005.tb03745.x 10.1002/path.2637 10.1073/pnas.1009353108 10.7314/APJCP.2013.14.11.6961 10.1038/sj.clpt.6100087 10.1002/jcb.22570 10.1158/1078-0432.CCR-12-1983 10.1007/s12032-009-9297-6 10.1111/j.1744-313X.2007.00678.x 10.1371/journal.pone.0048834 10.1136/bmj.e614 10.1016/j.molcel.2010.09.015 10.3892/etm.2012.469 10.1083/jcb.200706150 10.1074/jbc.M710579200 10.1016/j.molcel.2010.09.014 10.1083/jcb.200706179 10.1089/dna.2012.1718 10.1016/j.ygyno.2005.06.007 10.1101/gad.177444.111 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM |
DOI | 10.7314/APJCP.2014.15.16.6505 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2476-762X |
EndPage | 6510 |
ExternalDocumentID | 25169478 10_7314_APJCP_2014_15_16_6505 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- .UV 23N 2WC 53G 5GY 9ZL AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV CITATION E3Z EBS EJD F5P FRJ GROUPED_DOAJ GX1 JDI OK1 OVT RPM TR2 W2D WOW CGR CUY CVF ECM EIF NPM |
ID | FETCH-LOGICAL-c356t-90d69c1b347f26fc0a697e5a8a56f8c48498fdcfc3fabc742b882287dab36e3b3 |
ISSN | 1513-7368 |
IngestDate | Fri Sep 17 21:48:51 EDT 2021 Thu Apr 24 23:02:53 EDT 2025 Tue Jul 01 04:31:32 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c356t-90d69c1b347f26fc0a697e5a8a56f8c48498fdcfc3fabc742b882287dab36e3b3 |
OpenAccessLink | http://koreascience.or.kr:80/article/JAKO201429765166956.pdf |
PMID | 25169478 |
PageCount | 6 |
ParticipantIDs | pubmed_primary_25169478 crossref_primary_10_7314_APJCP_2014_15_16_6505 crossref_citationtrail_10_7314_APJCP_2014_15_16_6505 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-01-01 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Thailand |
PublicationPlace_xml | – name: Thailand |
PublicationTitle | Asian Pacific journal of cancer prevention : APJCP |
PublicationTitleAlternate | Asian Pac J Cancer Prev |
PublicationYear | 2014 |
References | (POCPA9_2014_v15n16_6505_009) 2010; 27 (POCPA9_2014_v15n16_6505_014) 2012; 131 (POCPA9_2014_v15n16_6505_017) 2008; 283 (POCPA9_2014_v15n16_6505_003) 2012; 26 (POCPA9_2014_v15n16_6505_005) 2010; 40 (POCPA9_2014_v15n16_6505_007) 2010; 110 (POCPA9_2014_v15n16_6505_008) 2012; 3 (POCPA9_2014_v15n16_6505_021) 2011; 108 (POCPA9_2014_v15n16_6505_029) 2013; 32 (POCPA9_2014_v15n16_6505_035) 2013; 8 (POCPA9_2014_v15n16_6505_025) 2010; 18 (POCPA9_2014_v15n16_6505_015) 2012; 18 (POCPA9_2014_v15n16_6505_020) 2009; 7 (POCPA9_2014_v15n16_6505_016) 2010; 220 POCPA9_2014_v15n16_6505_028 (POCPA9_2014_v15n16_6505_002) 2012; 7 (POCPA9_2014_v15n16_6505_018) 2010; 197 (POCPA9_2014_v15n16_6505_010) 2007; 81 (POCPA9_2014_v15n16_6505_027) 2007; 27 (POCPA9_2014_v15n16_6505_034) 2012; 205 (POCPA9_2014_v15n16_6505_012) 2013; 33 (POCPA9_2014_v15n16_6505_026) 2005; 49 (POCPA9_2014_v15n16_6505_013) 2007; 34 (POCPA9_2014_v15n16_6505_019) 2007; 179 (POCPA9_2014_v15n16_6505_011) 2012; 344 (POCPA9_2014_v15n16_6505_032) 1998; 393 (POCPA9_2014_v15n16_6505_001) 2010; 40 (POCPA9_2014_v15n16_6505_024) 2009; 29 POCPA9_2014_v15n16_6505_030 (POCPA9_2014_v15n16_6505_023) 2010; 70 (POCPA9_2014_v15n16_6505_031) 2009; 15 (POCPA9_2014_v15n16_6505_033) 2007; 179 POCPA9_2014_v15n16_6505_036 (POCPA9_2014_v15n16_6505_004) 2005; 99 (POCPA9_2014_v15n16_6505_022) 2012; 15 (POCPA9_2014_v15n16_6505_006) 2006; 26 |
References_xml | – volume: 33 start-page: 2561 year: 2013 ident: POCPA9_2014_v15n16_6505_012 publication-title: Anticancer Res – volume: 29 start-page: 2278 year: 2009 ident: POCPA9_2014_v15n16_6505_024 publication-title: Mol Cell Biol doi: 10.1128/MCB.01768-08 – volume: 205 start-page: 373 year: 2012 ident: POCPA9_2014_v15n16_6505_034 publication-title: Cancer Genet doi: 10.1016/j.cancergen.2012.04.010 – volume: 7 start-page: 1645 year: 2009 ident: POCPA9_2014_v15n16_6505_020 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-09-0117 – volume: 15 start-page: 79 year: 2012 ident: POCPA9_2014_v15n16_6505_022 publication-title: Twin Res Hum Genet doi: 10.1375/twin.15.1.79 – volume: 15 start-page: 6292 year: 2009 ident: POCPA9_2014_v15n16_6505_031 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-09-0826 – volume: 131 start-page: 1318 year: 2012 ident: POCPA9_2014_v15n16_6505_014 publication-title: Int J Cancer doi: 10.1002/ijc.27352 – volume: 27 start-page: 636 year: 2007 ident: POCPA9_2014_v15n16_6505_027 publication-title: Mol Cell doi: 10.1016/j.molcel.2007.07.012 – ident: POCPA9_2014_v15n16_6505_028 doi: 10.7314/APJCP.2012.13.12.6423 – volume: 70 start-page: 2789 year: 2010 ident: POCPA9_2014_v15n16_6505_023 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-3541 – ident: POCPA9_2014_v15n16_6505_036 doi: 10.7314/APJCP.2012.13.10.4909 – volume: 393 start-page: 229 year: 1998 ident: POCPA9_2014_v15n16_6505_032 publication-title: Nature doi: 10.1038/30400 – volume: 197 start-page: 174 year: 2010 ident: POCPA9_2014_v15n16_6505_018 publication-title: Cancer Genetics and Cytogenetics doi: 10.1016/j.cancergencyto.2009.11.011 – volume: 8 start-page: e77024 year: 2013 ident: POCPA9_2014_v15n16_6505_035 publication-title: PLoS ONE doi: 10.1371/journal.pone.0077024 – volume: 49 start-page: 417 year: 2005 ident: POCPA9_2014_v15n16_6505_026 publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.2005.tb03745.x – volume: 220 start-page: 164 year: 2010 ident: POCPA9_2014_v15n16_6505_016 publication-title: J Pathology doi: 10.1002/path.2637 – volume: 108 start-page: 3116 year: 2011 ident: POCPA9_2014_v15n16_6505_021 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1009353108 – ident: POCPA9_2014_v15n16_6505_030 doi: 10.7314/APJCP.2013.14.11.6961 – volume: 81 start-page: 328 year: 2007 ident: POCPA9_2014_v15n16_6505_010 publication-title: Clinical Pharmacology & Therapeutics doi: 10.1038/sj.clpt.6100087 – volume: 110 start-page: 609 year: 2010 ident: POCPA9_2014_v15n16_6505_007 publication-title: J Cell Biochem doi: 10.1002/jcb.22570 – volume: 18 start-page: 6407 year: 2012 ident: POCPA9_2014_v15n16_6505_015 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-1983 – volume: 27 start-page: 861 year: 2010 ident: POCPA9_2014_v15n16_6505_009 publication-title: Med Oncol doi: 10.1007/s12032-009-9297-6 – volume: 34 start-page: 213 year: 2007 ident: POCPA9_2014_v15n16_6505_013 publication-title: Int J Immunogenet doi: 10.1111/j.1744-313X.2007.00678.x – volume: 7 start-page: e48834 year: 2012 ident: POCPA9_2014_v15n16_6505_002 publication-title: PLoS One doi: 10.1371/journal.pone.0048834 – volume: 344 start-page: e614 year: 2012 ident: POCPA9_2014_v15n16_6505_011 publication-title: BMJ doi: 10.1136/bmj.e614 – volume: 40 start-page: 22 year: 2010 ident: POCPA9_2014_v15n16_6505_005 publication-title: Mol Cell doi: 10.1016/j.molcel.2010.09.015 – volume: 3 start-page: 689 year: 2012 ident: POCPA9_2014_v15n16_6505_008 publication-title: Exp Ther Med doi: 10.3892/etm.2012.469 – volume: 179 start-page: 1337 year: 2007 ident: POCPA9_2014_v15n16_6505_019 publication-title: J Cell Biol doi: 10.1083/jcb.200706150 – volume: 283 start-page: 19478 year: 2008 ident: POCPA9_2014_v15n16_6505_017 publication-title: J Biol Chem doi: 10.1074/jbc.M710579200 – volume: 40 start-page: 9 year: 2010 ident: POCPA9_2014_v15n16_6505_001 publication-title: Mol Cell doi: 10.1016/j.molcel.2010.09.014 – volume: 179 start-page: 1413 year: 2007 ident: POCPA9_2014_v15n16_6505_033 publication-title: J Cell Biol doi: 10.1083/jcb.200706179 – volume: 32 start-page: 19 year: 2013 ident: POCPA9_2014_v15n16_6505_029 publication-title: DNA Cell Biol doi: 10.1089/dna.2012.1718 – volume: 18 start-page: 453 year: 2010 ident: POCPA9_2014_v15n16_6505_025 publication-title: Oncol Res – volume: 26 start-page: 3745 year: 2006 ident: POCPA9_2014_v15n16_6505_006 publication-title: Anticancer Res – volume: 99 start-page: 176 year: 2005 ident: POCPA9_2014_v15n16_6505_004 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2005.06.007 – volume: 26 start-page: 325 year: 2012 ident: POCPA9_2014_v15n16_6505_003 publication-title: Genes & Dev doi: 10.1101/gad.177444.111 |
SSID | ssj0045875 |
Score | 2.0910993 |
Snippet | This study was conducted to identify whether polymorphic variants of set domain-containing protein 8 (SET8) and tumor protein p53 (TP53) codon 72, either... |
SourceID | pubmed crossref |
SourceType | Index Database Enrichment Source |
StartPage | 6505 |
SubjectTerms | 3' Untranslated Regions - genetics Asian Continental Ancestry Group - genetics Base Sequence Binding Sites - genetics China Female Gene Frequency Genetic Association Studies Genetic Predisposition to Disease Histone-Lysine N-Methyltransferase - genetics Humans MicroRNAs - genetics Middle Aged Polymorphism, Restriction Fragment Length Polymorphism, Single Nucleotide Sequence Analysis, DNA Tumor Suppressor Protein p53 - genetics Uterine Cervical Neoplasms - genetics |
Title | Association of a miR-502-Binding Site Single Nucleotide Polymorphism in the 3'-Untranslated Region of SET8 and the TP53 Codon 72 Polymorphism with Cervical Cancer in the Chinese Population |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25169478 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAviO-NL_kBxANKiWM7Th5HGZqqtaq2VoynyE6cEWmk0-he-Nv4u3jmLnbStJqA8WJVif1Lk_vFvrvcnQl5HVrNIpWGQaE0D8D-KoJURjYIdSgLnQBFLGYjT6bx4UKMT-XpYPCrF7V0tTLD_Me1eSX_I1U4BnLFLNkbSLYDhQPwG-QLLUgY2n-Sce_ZujzHb9VxIGHy-VC5ZJUTUCihqc_O7bspVi5erqrCYtAbmPzwhHGHDB_oyN9EKligq7cGlqAeemzPPPDJwTzpQi3nM8lhGinglIo2oRqn7qiZfdAngYS6bPFxo277Ha_d7hjW14v3m1xOHyHYL2eRO5ALX2kKuYquzNl41CWmfWld3l_1MvhYrb-qNIEKcDY4qrpXYFz53jPb9TxqOn72SXHeBcJEzwXiZ23GA8Xd_jzdtC779O1P0qCUyt6CH0sXWLu9mCjOBBa1wDvCGEAxZHLI4uF6eL9499ai2oU6gpGFQFkDkyFMxmTG4gxhbpHbkQKdr3UFOA1CyKQpEN3dlss8Q5j31_6bDZ1qwzpqtKT5fXLPmzd033H1ARnY-iG5M_EBHI_Izx5l6bKkmm5RliJlqaMsXVOW9nlGq5oCpSh_u0FY6giLsEhYCoRtuiFhaUNYqqJNICQsbQlLHWFbdE9YuibsY7L4dDAfHQZ-A5Eg5zJeBWlYxGnODBeqjOIyD3WcKit1omVcJrlIRJqURV7mvNQmVyIyYG9GiSq04bHlhj8hO_WytruEpkZwWxbCMgMau2YGi1IZUzJYweK4FHtEtCLIcl9dHzd5Oc_-SIA9MuyGXbjyMn8b8NTJt-se4ZduoZJnN4V6Tu6uX6YXZGd1eWVfgoa9Mq8aOkI7nU1-A6Wdy5o |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+a+miR-502-Binding+Site+Single+Nucleotide+Polymorphism+in+the+3%27-Untranslated+Region+of+SET8+and+the+TP53+Codon+72+Polymorphism+with+Cervical+Cancer+in+the+Chinese+Population&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Yang%2C+Shao-Di&rft.au=Cai%2C+Yan-Lin&rft.au=Jiang%2C+Pei&rft.au=Li%2C+Wen&rft.date=2014-01-01&rft.issn=1513-7368&rft.volume=15&rft.issue=16&rft.spage=6505&rft.epage=6510&rft_id=info:doi/10.7314%2FAPJCP.2014.15.16.6505&rft.externalDBID=n%2Fa&rft.externalDocID=10_7314_APJCP_2014_15_16_6505 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1513-7368&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1513-7368&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1513-7368&client=summon |